These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26468877)

  • 1. An in vitro assessment of liposomal topotecan simulating metronomic chemotherapy in combination with radiation in tumor-endothelial spheroids.
    Jyoti A; Fugit KD; Sethi P; McGarry RC; Anderson BD; Upreti M
    Sci Rep; 2015 Oct; 5():15236. PubMed ID: 26468877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model.
    Saito R; Krauze MT; Noble CO; Drummond DC; Kirpotin DB; Berger MS; Park JW; Bankiewicz KS
    Neuro Oncol; 2006 Jul; 8(3):205-14. PubMed ID: 16723630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ion-Pairing Contribution to the Liposomal Transport of Topotecan as Revealed by Mechanistic Modeling.
    Fugit KD; Anderson BD
    J Pharm Sci; 2017 Apr; 106(4):1149-1161. PubMed ID: 28007561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan.
    Fugit KD; Anderson BD
    J Control Release; 2014 Jan; 174():88-97. PubMed ID: 24231406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo studies of different liposomes containing topotecan.
    Hao YL; Deng YJ; Chen Y; Wang XM; Zhong HJ; Suo XB
    Arch Pharm Res; 2005 May; 28(5):626-35. PubMed ID: 15974453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic potential of camptothecin and topotecan.
    Clements MK; Jones CB; Cumming M; Daoud SS
    Cancer Chemother Pharmacol; 1999; 44(5):411-6. PubMed ID: 10501915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into accelerated liposomal release of topotecan in plasma monitored by a non-invasive fluorescence spectroscopic method.
    Fugit KD; Jyoti A; Upreti M; Anderson BD
    J Control Release; 2015 Jan; 197():10-9. PubMed ID: 25456833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells.
    Winter U; Mena HA; Negrotto S; Arana E; Pascual-Pasto G; Laurent V; Suñol M; Chantada GL; Carcaboso AM; Schaiquevich P
    PLoS One; 2016; 11(7):e0160094. PubMed ID: 27467588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of A-966492 and Topotecan for effective radiosensitization on glioblastoma spheroids.
    Koosha F; Neshasteh-Riz A; Takavar A; Eyvazzadeh N; Mazaheri Z; Eynali S; Mousavi M
    Biochem Biophys Res Commun; 2017 Sep; 491(4):1092-1097. PubMed ID: 28797568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
    Gerrits CJ; Burris H; Schellens JH; Eckardt JR; Planting AS; van der Burg ME; Rodriguez GI; Loos WJ; van Beurden V; Hudson I; Fields S; Von Hoff DD; Verweij J
    Clin Cancer Res; 1998 May; 4(5):1153-8. PubMed ID: 9607572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of vincristine-topotecan combination--paving the way for improved chemotherapy regimens by nanoliposomes.
    Zucker D; Barenholz Y
    J Control Release; 2010 Sep; 146(3):326-33. PubMed ID: 20685223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F7 and topotecan co-loaded thermosensitive liposome as a nano-drug delivery system for tumor hyperthermia.
    Du C; Li S; Li Y; Galons H; Guo N; Teng Y; Zhang Y; Li M; Yu P
    Drug Deliv; 2020 Dec; 27(1):836-847. PubMed ID: 32508162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple and efficient liposomal encapsulation of topotecan by ammonium sulfate gradient: stability, pharmacokinetic and therapeutic evaluation.
    Liu JJ; Hong RL; Cheng WF; Hong K; Chang FH; Tseng YL
    Anticancer Drugs; 2002 Aug; 13(7):709-17. PubMed ID: 12187327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence.
    Rowinsky EK; Kaufmann SH; Baker SD; Grochow LB; Chen TL; Peereboom D; Bowling MK; Sartorius SE; Ettinger DS; Forastiere AA; Donehower RC
    J Clin Oncol; 1996 Dec; 14(12):3074-84. PubMed ID: 8955652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
    Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
    J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topotecan Liposomes: A Visit from a Molecular to a Therapeutic Platform.
    Saraf S; Jain A; Hurkat P; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2016; 33(5):401-432. PubMed ID: 27910741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro assay for measuring real time topotecan release from liposomes: release kinetics and cellular internalization.
    Gilabert-Oriol R; Chernov L; Anantha M; Dragowska WH; Bally MB
    Drug Deliv Transl Res; 2017 Aug; 7(4):544-557. PubMed ID: 28432657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell lines.
    Zamboni WC; Houghton PJ; Hulstein JL; Kirstein M; Walsh J; Cheshire PJ; Hanna SK; Danks MK; Stewart CF
    Cancer Chemother Pharmacol; 1999; 43(4):269-76. PubMed ID: 10071976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-sensitive liposomes bearing a chemotherapeutic agent and a natural apoptosis modulator for effective intracellular delivery to the solid tumor.
    Saraf S; Jain SK
    Drug Deliv Transl Res; 2023 Dec; 13(12):2961-2981. PubMed ID: 37306925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.